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The human distal gut hosts a bustling 
community comprising thousands of 
different kinds of bacteria. Fortunately, 
most of these intestinal residents 
don’t cause disease but instead play 
key roles in nutrition, metabolism, 
pathogen resistance, and immune 
response regulation. Unfortunately, 
these beneficial bacteria are just as 
susceptible to the antibiotics we take to 
treat pathogenic bacteria. Antibiotics 
drastically alter the balance among 
members of different taxa of beneficial 
distal gut bacteria that have coevolved 
with one another and with their human 
host.
To date, researchers have had 
a limited understanding of what 
occurs in the gut during antibiotic 
treatment. Antibiotic-related changes 
in the distal gut bacterial community 
can cause acute or chronic disease 
in humans, ranging in severity from 
temporary diarrhea to the potentially 
fatal disorder pseudomembranous 
colitis. Antibiotic use during childhood 
and the resulting alterations in the 
gut microbial community have also 
been linked to asthma. Although the 
bacterial community generally returns 
to its pretreatment composition days 
or weeks after antibiotic treatment has 
ended, antibiotic effects on specific 
bacterial taxa can last for years. How 
antibiotics affect bacteria at the species 
and strain level, where the community 
is most diverse, remains obscure. 
To find out more about the changes 
taking place in the gut during 
antibiotic treatment, Les Dethlefsen et 
al. extracted DNA from stool samples 
collected from three healthy adults 
before, during, and after treatment 
for five days with ciprofloxacin (a 
broad-spectrum antibiotic that is 
used to treat a variety of bacterial 
conditions such as infections of the 
lower respiratory or urinary tracts  
and sexually transmitted infections). 
Although the unnecessary use of 
antibiotics is a general problem 
in most populations globally, 
ciprofloxacin was selected because 
of its safety profile and the previous 
belief that it does not harm the most 
abundant commensal bacteria of 
the distal gut. Then, to differentiate 
among bacterial taxa, the researchers 
analyzed the 16S rRNA gene, a 
universally conserved gene containing 
hypervariable regions, by using 
traditional full-length gene sequencing 
and a newly developed sequencing 
technique called pyrosequencing. 
Pyrosequencing has been used to 
investigate the taxonomic richness 
of microbes living in marine deep 
water, hydrothermal vents, and other 
environments. It works by detecting 
light that’s emitted as the result of 
an enzymatic reaction during DNA 
synthesis, using the sample DNA (in 
this case, the hypervariable regions 
V6 and V3 in the 16S rRNA gene) 
as a template. Pyrosequencing 
improves on older DNA sequencing 
techniques in its ability to deliver large 
amounts of genetic sequence data at a 
significantly lower cost. A companion 
paper published this month in PLoS
Genetics, “Exploring Microbial Diversity 
and Taxonomy Using SSU rRNA 
Hypervariable Tag Sequencing,” by 
Susan Huse and colleagues (doi: 
10.1371/journal.pgen.1000255),
demonstrated the reliability of 
this technique by comparing the 
taxonomic information yielded by 
traditional full-length sequencing of 
bacterial 16S rRNA genes with that 
yielded by pyrosequencing of only the 
hypervariable regions. They found that 
both methods yielded similar results 
about the composition of bacterial 
communities.
Using more than 7,000 full-length 
16S rRNA gene sequences and over 
900,000 pyrosequencing reads from 
the hypervariable regions of the same 
gene, Dethlefsen et al. confirmed 
the presence of over 5,600 bacterial 
taxa in the human gut—far more 
taxonomic richness than had been 
seen in previous investigations of 
host-associated bacterial communities. 
They also found that ciprofloxacin 
had a dramatic effect on microbial 
communities and that the specific 
bacterial taxa most strongly affected 
varied among the human hosts. 
Ciprofloxacin treatment caused 
a sizeable decrease in taxonomic 
richness in two of the participants, 
while bacterial diversity was somewhat 
less strongly affected in the third 
participant. The relative abundance 
levels of about 30% of bacterial taxa 
in the human hosts were affected 
by treatment. Most members of 
the bacterial community returned 
to pretreatment numbers within 
four weeks following treatment. 
Although the effects on their gut 
inhabitants were profound, none of 
the participants reported any changes 
in their gut function either during or 
after treatment, indicating that the 
tremendous diversity of the distal gut 
bacterial community makes it both 
resilient and functionally redundant. 
Although participants reported no 
signs of gut-related problems and the 
overall post-treatment composition 
of the community was similar to that 
before ciprofloxacin treatment, some 
taxa had not recovered completely 
even six months later. Because 
specific bacterial taxa are responsible 
for different aspects of nutrition, 
metabolism, and immune response, 
even seemingly minor changes in 
the composition of the gut microbial 
community as the result of antibiotic 
treatment might have long-term 
effects on health that could go 
undetected in the relatively short 
length of the study.
Now that pyrosequencing has 
been shown to be a fast, precise, and 
cost-effective way to investigate host-
associated microbial communities, 
it can be applied to many as-yet 
unanswered questions, including 
pinpointing the factors responsible 
for bacterial community resilience. 
The researchers suggest that 
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This comprehensive survey of bacterial 
diversity in the human gut shows extensive 
but temporary changes in the microbial 
community following ciprofloxacin 
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resilience may arise from a mix of 
selective forces, both intrinsic to 
the bacterial community (such as 
different growth rates and substrate 
affinities) and imposed by the 
environment (such as differences 
in the host diets and host-derived 
substrates). Understanding how 
resilience arises and how the bacteria 
of the distal gut are affected by 
antibiotic treatment may also be 
clinically useful. For example, 
characterizing the relative abundance 
of both rare and more populous taxa 
over time may help clinicians predict 
the likelihood of patients developing 
antibiotic-associated diarrhea due to 
the overgrowth of harmful bacteria. 
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